| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 47.61B | 49.16B | 44.10B | 39.66B | 38.85B | 37.87B |
| Gross Profit | 13.73B | 13.99B | 12.11B | 10.32B | 10.50B | 10.19B |
| EBITDA | 3.62B | 4.46B | 2.99B | 2.02B | 3.41B | 2.98B |
| Net Income | 1.61B | 2.01B | 1.31B | 1.02B | 1.65B | 2.08B |
Balance Sheet | ||||||
| Total Assets | 63.12B | 63.73B | 62.23B | 52.13B | 52.08B | 48.70B |
| Cash, Cash Equivalents and Short-Term Investments | 14.69B | 14.04B | 15.55B | 10.32B | 12.44B | 12.49B |
| Total Debt | 10.19B | 10.25B | 10.72B | 5.76B | 3.81B | 2.49B |
| Total Liabilities | 29.25B | 29.16B | 29.14B | 20.52B | 20.03B | 17.25B |
| Stockholders Equity | 33.83B | 34.55B | 33.03B | 31.64B | 32.00B | 31.43B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 76.00M | 2.01B | -3.82B | 527.00M | 370.00M |
| Operating Cash Flow | 0.00 | 2.99B | 4.33B | -1.64B | 2.22B | 2.78B |
| Investing Cash Flow | 0.00 | -2.81B | -2.33B | -1.23B | -2.17B | -1.87B |
| Financing Cash Flow | 0.00 | -1.75B | 3.19B | 710.00M | -282.00M | -1.13B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥18.72B | 11.81 | ― | 3.29% | -1.36% | 5.14% | |
74 Outperform | ¥31.16B | 17.22 | ― | 4.26% | -4.23% | -1.63% | |
73 Outperform | ¥52.79B | 25.15 | ― | 2.76% | -10.66% | -38.53% | |
70 Outperform | ¥19.17B | 33.20 | ― | 5.14% | -13.63% | -74.53% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
45 Neutral | ¥40.40B | 24.79 | ― | 1.56% | 10.90% | ― | |
43 Neutral | ¥16.03B | -6.03 | ― | 5.40% | -2.22% | 18.80% |